Wednesday, 16 Jan 2019

You are here

The RheumNow Week in Review - 23 March 2018

Dr. Jack Cush reviews the highlights from the news, journals and major meetings. New announcements and approval from the FDA; novel associations between ANCA vasculitis and thyroid disease; flare rates after arthroplasty; and pregnancy outcomes for men and women.

  1. FDA Arthritis Advisory Committee will meet on April 23rd to discuss the NDA for Eli Lilly's JAK inhibitor - baricitinib in moderate to severe RA. Discussion will be around risk:benefit assessment, dose selection & the risk of venous thromboembolic events. https://t.co/dQ4AdYZyQx
  2. FDA Approves Ilumya (tildrakizumab) for Moderate-to-Severe Plaque Psoriasis. It binds p19 subunit of IL-23, inhibiting binding to IL-23 receptor. Given as 100 mg sc at Wk 0, 4 & q 12wks; this is the2nd IL-23 inhib approved for Pso. https://t.co/q9bQTVqN0t
  3. Norfolk registry study of 431 inflammatory arthritis pts shows 82% still on MTX after 2 years. Early MTX failure associated with RF+, younger onset age, high DAS-28. MTX discontinuations for AE less likely if RF-positive https://t.co/kOrfaCnZaf
  4. In a RCT of 106 hip osteoarthritis patients, intramuscular glucocorticoid injection shown to be significantly better than placebo injx in all outcomes for up to 12-weeks https://t.co/csGXkQQwjh
  5. Study from German RABBIT Registry of 885 RA patients treated with tocilizumab finds that treatment success with TCZ similar in pts with no, 1 or 2 prior bDMARD failures, but less with with ≥ 3 bDMARD failures. https://t.co/jAriEaPruP
  6. Study of 279 patients with ANCA Associated vasculitis shows a high prevalence of thyroid disease - 21.5% - mostly females with MPO Abs and renal disease. https://t.co/7QGZrcSnLJ
  7. Flares are frequent in patients in 120 RA undergoing arthroplasty (THA, TKA); by 6 wks 63%. Flare more freq with higher disease activity (OR=2), ESR, CRP, Pain; but not affected by biologic use. https://t.co/4hdn5nTQZO
  8. Pregnancy study from Quebec finds 51 Pregs exposed to leflunomide during 1st trimester; 21 during the 2nd/3rd trimesters but was not associated with an increased risk of congenital malformations, Spont Ab, low birth weight or prematurity https://t.co/WiqyOkg3L2
  9. Danish/Swedish study of 8097 births in 6103 psoriasis women & 964 births in 753 PsA women shows increased number of maternal gestational DM, HTN & preeclampsia; and more cesarean delivery, pre-term birth & low birth weight infants; moreso with severe psoriasis https://t.co/DjrNqiRlgA
  10. Risk of Paternal Exposure to Anti-Rheumatic Drugs  
  11. Shoe Inserts Disappoint with Plantar Heel Pain  
  12. mTOR Inhibition with Sirolimus Effective in Lupus  

 

Disclosures: 
The author has received compensation as an advisor or consultant on this subject

Add new comment

More Like This

Assessing the Performance of Aging Physicians

A JAMA Viewpoint article examines the performance of aging surgeons and notes that the effects of aging affects physicians variably and that physician competency should be based on functional age (and abilities) rather than chronologic age. This argues against a mandatory retirement age for surgeons.

RheumNow Podcast – Gout Spot Light (1.11.19)

Dr. Jack Cush discusses the highlights from the past week on RheumNow.com:

RheumNow Podcast – A Grand New Year (1.4.19)

Dr. Jack Cush reviews the news and journals for the beginning of 2019. All from RheumNow.com. Best wishes for a charmed 2019! My advice: 1. Just show up. 2. If you can, then you must do. 3. Live each day as if it twas your 1st day/last day/make or break day. 4. Teach.

Best of 2018: U.S. News 2018-19 Rheumatology Rankings

The Annual U.S. News and World Report Rankings of Hospitals has listed the top contenders in the field of rheumatology. The U.S. News Review rates hospitals nationwide in 16 specialties – including rheumatology. Of the 4,500 hospitals covered by U.S. News that were analyzed, 158 were classified nationally in at least one specialty area.

RheumNow Podcast – Rheumatologist Salaries (12.21.18)

Dr. Jack Cush reviews the news from RheumNow for the week ending 12/21/18.